The lncRNA 'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels
A Wambecke, M Ahmad, PM Morice… - Molecular …, 2021 - Wiley Online Library
Ovarian cancer (OC) is the leading cause of death in patients with gynecologic cancers. Due
to late diagnosis and resistance to chemotherapy, the 5‐year survival rate in patients with …
to late diagnosis and resistance to chemotherapy, the 5‐year survival rate in patients with …
The lncRNA'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
A Wambecke, M Ahmad, PM Morice… - Molecular …, 2021 - hal.insa-toulouse.fr
Ovarian cancer (OC) is the leading cause of death in patients with gynecologic cancers. Due
to late diagnosis and resistance to chemotherapy, the 5-year survival rate in patients with …
to late diagnosis and resistance to chemotherapy, the 5-year survival rate in patients with …
[HTML][HTML] The lncRNA 'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels
A Wambecke, M Ahmad, PM Morice, B Lambert… - Molecular …, 2021 - ncbi.nlm.nih.gov
Ovarian cancer (OC) is the leading cause of death in patients with gynecologic cancers. Due
to late diagnosis and resistance to chemotherapy, the 5‐year survival rate in patients with …
to late diagnosis and resistance to chemotherapy, the 5‐year survival rate in patients with …
The lncRNA'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
A Wambecke, M Ahmad, PM Morice, B Lambert… - Molecular …, 2021 - hal.univ-lille.fr
Ovarian cancer (OC) is the leading cause of death in patients with gynecologic cancers. Due
to late diagnosis and resistance to chemotherapy, the 5-year survival rate in patients with …
to late diagnosis and resistance to chemotherapy, the 5-year survival rate in patients with …
The lncRNA'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
A Wambecke, M Ahmad, PM Morice, B Lambert… - Molecular …, 2021 - lilloa.univ-lille.fr
Ovarian cancers are the leading cause of death from gynecologic malignancies. They
represent the 7th most frequent cancer in women worldwide and are responsible for around …
represent the 7th most frequent cancer in women worldwide and are responsible for around …
[PDF][PDF] The lncRNA 'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels
A Wambecke, M Ahmad, PM Morice, B Lambert… - researchgate.net
Ovarian cancers are the leading cause of death from gynecologic malignancies. They
represent the 7th most frequent cancer in women worldwide and are responsible for around …
represent the 7th most frequent cancer in women worldwide and are responsible for around …
The lncRNA 'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels
A Wambecke, M Ahmad, PM Morice… - Molecular …, 2021 - search.proquest.com
Ovarian cancer (OC) is the leading cause of death in patients with gynecologic cancers. Due
to late diagnosis and resistance to chemotherapy, the 5‐year survival rate in patients with …
to late diagnosis and resistance to chemotherapy, the 5‐year survival rate in patients with …
The lncRNA'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
A Wambecke, M Ahmad, PM Morice, B Lambert… - Molecular …, 2021 - europepmc.org
Ovarian cancer (OC) is the leading cause of death in patients with gynecologic cancers. Due
to late diagnosis and resistance to chemotherapy, the 5‐year survival rate in patients with …
to late diagnosis and resistance to chemotherapy, the 5‐year survival rate in patients with …
The lncRNA'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels
A Wambecke, M Ahmad, PM Morice… - Molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Ovarian cancer (OC) is the leading cause of death in patients with gynecologic cancers. Due
to late diagnosis and resistance to chemotherapy, the 5-year survival rate in patients with …
to late diagnosis and resistance to chemotherapy, the 5-year survival rate in patients with …
[引用][C] The lncRNA'UCA1'modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
A Wambecke, M Ahmad, PM Morice, B Lambert… - 2021 - lilloa.univ-lille.fr
The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct
binding to miR-27a-5p and control of UBE2N levels. Toggle navigation English français Aide …
binding to miR-27a-5p and control of UBE2N levels. Toggle navigation English français Aide …